list of glp 1 agonists for weight loss Market Overview: GLP-1 and the Obesity Market | Blog Compare GLP-1 Options | Ozempic
Description
Clinical research is necessary
As of September 2023, about 1.7% of people in the US had been prescribed a semaglutide medication, up 40-fold over the past five years, according to data shared exclusively with CNN by Epic Research that was based on an analysis of millions of electronic health records
For example, liraglutide has been shown to improve neural function through multiple signaling pathways, whereas semaglutide appears to exert more pronounced effects on neuroinflammation and neural tissue remodeling [11, 84, 86]
Weivoda et al
